Literature DB >> 25160484

Weight variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of use.

Waleska Modesto1, Priscila de Nazaré Silva dos Santos, Vinicius Machado Correia, Luiza Borges, Luis Bahamondes.   

Abstract

BACKGROUND AND
OBJECTIVE: Data on record regarding weight variation in depot-medroxyprogesterone acetate (DMPA) and levonorgestrel-releasing intrauterine system (LNG-IUS) users are controversial. To date, no studies have yet evaluated weight variation in DMPA and LNG-IUS users in up to ten years of use compared to non-hormonal contraceptive users.
MATERIALS AND METHODS: A retrospective study analysed weight variations in 2138 women using uninterruptedly DMPA (150 mg intramuscularly, three-monthly; n = 714), the LNG-IUS (n = 701) or a copper-intrauterine device (Cu-IUD; n = 723).
RESULTS: At the end of the first year of use, there was a mean weight increase of 1.3 kg, 0.7 kg and 0.2 kg among the DMPA-, LNG-IUS- and Cu-IUD users, respectively, compared to weight at baseline (p < 0.0001). After ten years of use, the mean weight had risen by 6.6 kg, 4.0 and 4.9 kg among the DMPA-, LNG-IUS- and Cu-IUD users, respectively. DMPA-users had gained more weight than LNG-IUS- (p = 0.0197) and than Cu-IUD users (p = 0.0294), with the latter two groups not differing significantly from each other in this respect (p = 0.5532).
CONCLUSION: Users of hormonal and non-hormonal contraceptive methods gained a significant amount of weight over the years. DMPA users gained more weight over the treatment period of up to ten years than women fitted with either a LNG-IUS or a Cu-IUD.

Entities:  

Keywords:  Copper IUD; Depot-medroxyprogesterone acetate; Levonorgestrel-releasing intrauterine system; Weight

Mesh:

Substances:

Year:  2014        PMID: 25160484     DOI: 10.3109/13625187.2014.951433

Source DB:  PubMed          Journal:  Eur J Contracept Reprod Health Care        ISSN: 1362-5187            Impact factor:   1.848


  10 in total

1.  Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception did not influence early discontinuation.

Authors:  Luis Bahamondes
Journal:  EClinicalMedicine       Date:  2021-04-14

2.  Effectiveness of progestin-based therapy for morbidly obese women with complex atypical hyperplasia.

Authors:  Marcia A Ciccone; Stephanie A Whitman; Charlotte L Conturie; Niquelle Brown; Christina E Dancz; Begum Özel; Koji Matsuo
Journal:  Arch Gynecol Obstet       Date:  2019-01-31       Impact factor: 2.344

3.  Levonorgestrel correlates with less weight gain than other progestins during hormonal replacement therapy in Turner Syndrome patients.

Authors:  Andréia Latanza Gomes Mathez; Patrícia Teófilo Monteagudo; Ieda Therezinha do Nascimento Verreschi; Magnus Régios Dias-da-Silva
Journal:  Sci Rep       Date:  2020-05-19       Impact factor: 4.379

4.  Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial.

Authors:  Mags Beksinska; Rodal Issema; Ivana Beesham; Tharnija Lalbahadur; Katherine Thomas; Charles Morrison; G Justus Hofmeyr; Petrus S Steyn; Nelly Mugo; Thesla Palanee-Phillips; Khatija Ahmed; Gonasagrie Nair; Jared M Baeten; Jenni Smit
Journal:  EClinicalMedicine       Date:  2021-04-06

5.  Contraceptive effectiveness, pharmacokinetics, and safety of Sayana® Press when injected every four months: a multicenter phase 3 trial.

Authors:  Jennifer Deese; Vivian Brache; Luis Bahamondes; Abril Salinas; Aidelis Jorge; Nelio Veiga; Rachael Fuchs; Ashley Miller; Doug Taylor; Vera Halpern; Laneta Dorflinger
Journal:  EClinicalMedicine       Date:  2022-01-29

Review 6.  Progestin-only contraceptives: effects on weight.

Authors:  Laureen M Lopez; Shanthi Ramesh; Mario Chen; Alison Edelman; Conrad Otterness; James Trussell; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2016-08-28

Review 7.  Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits.

Authors:  Anderson Sanches de Melo; Rosana Maria Dos Reis; Rui Alberto Ferriani; Carolina Sales Vieira
Journal:  Open Access J Contracept       Date:  2017-02-02

Review 8.  Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery.

Authors:  Clarissa Lam; Amitasrigowri S Murthy
Journal:  Open Access J Contracept       Date:  2016-09-29

9.  Association between progestin-only contraceptive use and cardiometabolic outcomes: A systematic review and meta-analysis.

Authors:  Marija Glisic; Sara Shahzad; Stergiani Tsoli; Mahmuda Chadni; Eralda Asllanaj; Lyda Z Rojas; Elizabeth Brown; Rajiv Chowdhury; Taulant Muka; Oscar H Franco
Journal:  Eur J Prev Cardiol       Date:  2018-05-10       Impact factor: 7.804

10.  Contraceptive Options Following Gestational Diabetes: Current Perspectives.

Authors:  Ashley M Turner; Emily A Donelan; Jessica W Kiley
Journal:  Open Access J Contracept       Date:  2019-10-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.